Latest news
Vaxcellbio Partners with Myellama to Advance Next-Generation NK Cell Therapy for Multiple Myeloma - BioPharma APACBioPharma APAC · Tue, 04 Aug 2026 18:34:56 GMTVaxcellbio launches global co-development program for NRC-based NK cell therapy for multiple myeloma - koreabiomed.comkoreabiomed.com · Tue, 04 Aug 2026 06:22:28 GMTResearchers Identify Donor NK Cell Subset That Impairs CAR NK Cell Therapy - The ASCO PostThe ASCO Post · Mon, 03 Aug 2026 15:37:18 GMTKaty Rezvani: New Cancer Cell Study Advances CAR NK Therapy - OncodailyOncodaily · Fri, 31 Jul 2026 15:51:12 GMTDonor cord blood composition may influence CAR NK cell therapy outcomes - mdanderson.orgmdanderson.org · Wed, 29 Jul 2026 07:00:00 GMT